Results
Over the study period between mid-April and mid-June 2020, sixty-one
children with cancer were admitted to the Pediatric Hematology Oncology
department, Children’s hospital, Ain Shams University. They were 38
(62.2%) males and 23 (37.7%) females. The underlying diagnosis was
mainly acute lymphoblastic leukemia (ALL) (n=42, 68.9%), bone tumor
(n=4, 6.5%), lymphoma (n=4, 6.5%), neuroblastoma (n=2, 3.3%), central
nervous system (CNS) tumors (n=3, 4.9%), hemophagocytic
lymphohistiocytosis (HLH) 2 (n=2, 3.2%), retinoblastoma (n=1, 1.6%),
Wilms tumor (n=1, 1.6%), germ cell tumor (n=1, 1.6%) and
rhabdomyosarcoma (n=1, 1.6%). All patients were admitted either for
their due chemotherapy cycle (n=29, 45.7%) or for a concurrent illness
that required supportive care (n=33, 54.3%). Forty-six (75%) patients
were discharged safely and 4 (6.5%) died during the admission.